*together with TradeAlgo & Brooks Enterprises
Good day, 360!
FOCUS LIST🔎
HYZN – Up over 100% in pre after announcing it has secured first hydrogen powered fuel cell electric refuse truck order in North America from waste industry pioneer Greenwaste
SOBR – Up over 20% in pre after announcing the launch of revolutionary alcohol detection software: transforming patient care for behavioral health providers
IMUX – Up over 17% in pre after announcing positive outcome of interim analysis of Phase 3 ENSURE program of Vidofludimus Calcium in relapsing Multiple Sclerosis
*together with TradeAlgo
Bronco Uses TradeGPT
Did you see Bronco ask TradeGPT what stock is RIPE in Jeff’s interview yesterday???
Yes…TradeGPT is a thing!
HOTLIST🔥
HYZN – Up over 100% in pre after announcing it has secured first hydrogen powered fuel cell electric refuse truck order in North America from waste industry pioneer Greenwaste
Hyzon Motors Inc. (HYZN) supplies hydrogen fuel cell systems for decarbonization applications in various industries.
In the pre-market this morning, the company announced it has entered into a purchase agreement for North America’s first 12 hydrogen-powered refuse Fuel Cell Electric Vehicles (FCEVs) with recycling and innovation pioneer GreenWaste®, contingent upon Hyzon meeting certain commercial terms and specifications as defined in the agreement.
Hyzon’s FCEVs are the first hydrogen-powered refuse collection FCEVs available for trial and purchase in North America, and GreenWaste is set to make history as the first company in North America to commercially operate them, continuing their commitment to sustainability leadership in the waste industry.
The purchase agreement comes on the back of GreenWaste’s trial of Hyzon’s refuse FCEV, where it successfully completed several trial routes throughout the Bay Area, testing for payload, can-lifts and range.
Refuse FCEV deliveries are expected to GreenWaste starting as soon as Q4 2025.Shares of HYZN traded up over 100% in the pre-market in reaction to the news.
The $3 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $3.29, $3.61, $4 and then the pre-market high at $4.28. Beyond that, $5.39 and $6.50 come into play.
Below $3, targets to the downside are $2.70, $2.30, $2 and then a gap fill at $1.93.
SOBR – Up over 20% in pre after announcing the launch of revolutionary alcohol detection software: transforming patient care for behavioral health providers
SOBR Safe, Inc. (SOBR) is a hardware and software company that develops non-invasive alcohol detection, biometric identity verification, and real-time cloud-based alerts and reporting systems in North America.
In the pre-market this morning, the company announced the launch of its fully-integrated enterprise software solution for point-of-care screening (SOBRcheck™) and continuous monitoring (SOBRsure™). This new innovative platform is expected to transform how health providers monitor and manage alcohol compliance, delivering unprecedented real-time visibility across multiple users and locations in one dynamic dashboard.
SOBRsafe’s innovative software offers real-time insights into alcohol use throughout the treatment journey, creating the first definitive electronic alcohol record across the continuum of care.
Shares of SOBR traded up over 20% in the pre-market in reaction to the news.
The $10.53 area acted as support in the pre-market and will ba an important level to watch.
Above it, targets to the upside are $12.50, $13 and then the pre-market high at $15.47.
Below $10.53, targets to the downside are $9.50 a gap fill at $9 and then $8.50 and $7.95 below that.
*together with Brooks Enterprises
Stephen Brooks is going LIVE to show you how his AI Trading Bot hunts for the best trades 24/7.
Once you register, you’ll receive THIS 👆sneak peak!
IMUX – Up over 17% in pre after announcing positive outcome of interim analysis of Phase 3 ENSURE program of Vidofludimus Calcium in relapsing Multiple Sclerosis
Immunic Inc. (IMUX) is a biotechnology company that develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
In the pre-market this morning, the company announced a positive outcome of the non-binding, interim futility analysis of its phase 3 ENSURE program, investigating lead asset, nuclear receptor related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), for the treatment of relapsing multiple sclerosis (RMS).
Based on the outcome of the interim futility analysis, an unblinded Independent Data Monitoring Committee (IDMC) has recommended that the trials are not futile and should continue as planned.
The ENSURE Program Remains on Track to be Completed in 2026.
Shares of IMUX traded up over 17% in the pre-market in reaction to the news.
The $1.70 area has acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $1.90, $2, $2.10 and then the pre-market high at $2.34. Beyond that, $2.45, $2.80 and $3.10 come into play.
Below $1.70, there is a gap to fill at $1.55 with $1.45 below that.
MARKET NEWS 📰
P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas!
Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
